COVID-19 Updates: What it Means For You

In May the NPF formed the NPF COVID-19 Task Force to help serve the psoriatic disease community by closely monitoring evolving data and advances. This Task Force is led by Co-Chairs, dermatologist Dr. Joel Gelfand (Director, Psoriasis and Phototherapy Treatment Center at Penn) and rheumatologist Dr. Christopher Ritchlin (Co-Director, Psoriasis Center and Director of the Clinical Immunology Research Unit, University of Rochester Medical Center) and includes experts from both the NPF Medical Board and Scientific Advisory Committee, as well as experts in dermatology, rheumatology, infectious disease and critical care.

Watch this webinar to hear Dr. Gelfand and Dr. Ritchlin explain the 22 guidance statements for psoriatic disease, what they mean for your psoriatic disease management during this pandemic, and the work of the Task Force. Discussion includes many of the questions you have about the use of biologics during the COVID-19 pandemic. You don’t want to miss this webinar!